States could get federal grants to screen for uterine fibroids and help patients get care sooner. The bill also funds research on pain during fibroid surgery and other uterus-related conditions.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 is a Senate bill in committee. The latest recorded action: Committee on Health, Education, Labor, and Pensions. Hearings held.
Latest action on S. 2531: Committee on Health, Education, Labor, and Pensions. Hearings held.
Who this affects: This bill mainly affects people who have, or may have, uterine fibroids. It could change how quickly they get screened, diagnosed, and guided into care. It also affects states, health care providers, researchers, and federal health officials because they would run or study the grant programs.
Why this matters: Fibroids can cause serious symptoms, but many people do not learn they have them until problems get worse. This bill tries to move care earlier by funding screening, imaging, patient support, and public education. It could also add evidence about pain care during surgery and about other conditions inside the uterus. The bill does not say how much money the programs would receive or how much clinical practice would change.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
